COLINZPharmaceuticals
Colinz Laboratories Ltd — Balance Sheet
₹44.50
+0.00%
Colinz Laboratories Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 0.25 Cr | 0.25 Cr | 0.25 Cr | 0.46 Cr | — |
| Share Issued | 0.25 Cr | 0.25 Cr | 0.25 Cr | 0.46 Cr | — |
| Total Debt | 0.64 Cr | 0.57 Cr | 0.27 Cr | 0.48 Cr | — |
| Tangible Book Value | 9.47 Cr | 8.95 Cr | 8.14 Cr | 7.69 Cr | — |
| Invested Capital | 10.12 Cr | 9.52 Cr | 8.41 Cr | 8.17 Cr | — |
| Working Capital | 6.85 Cr | 6.55 Cr | 5.95 Cr | 5.40 Cr | — |
| Net Tangible Assets | 9.47 Cr | 8.95 Cr | 8.14 Cr | 7.69 Cr | — |
| Common Stock Equity | 9.47 Cr | 8.95 Cr | 8.14 Cr | 7.69 Cr | — |
| Total Capitalization | 9.47 Cr | 8.95 Cr | 8.14 Cr | 7.69 Cr | — |
| Total Equity Gross Minority Interest | 9.47 Cr | 8.95 Cr | 8.14 Cr | 7.69 Cr | — |
| Stockholders Equity | 9.47 Cr | 8.95 Cr | 8.14 Cr | 7.69 Cr | — |
| Other Equity Interest | 6.96 Cr | 6.43 Cr | 5.62 Cr | 4.14 Cr | — |
| Capital Stock | 2.52 Cr | 2.52 Cr | 2.52 Cr | 3.54 Cr | — |
| Common Stock | 2.52 Cr | 2.52 Cr | 2.52 Cr | 3.54 Cr | — |
| Total Liabilities Net Minority Interest | 2.34 Cr | 2.41 Cr | 2.09 Cr | 2.24 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 0.18 Cr | 0.23 Cr | 0.21 Cr | 0.26 Cr | — |
| Non Current Deferred Taxes Liabilities | 0.18 Cr | 0.23 Cr | 0.21 Cr | 0.26 Cr | — |
| Current Liabilities | 2.16 Cr | 2.18 Cr | 1.89 Cr | 1.98 Cr | — |
| Other Current Liabilities | 0.86 Cr | 0.22 Cr | 0.20 Cr | 0.26 Cr | — |
| Current Debt And Capital Lease Obligation | 0.64 Cr | 0.57 Cr | 0.27 Cr | 0.48 Cr | — |
| Current Debt | 0.64 Cr | 0.57 Cr | 0.27 Cr | 0.48 Cr | — |
| Current Provisions | 0.12 Cr | 0.09 Cr | 0.09 Cr | 0.13 Cr | — |
| Payables | 0.54 Cr | 0.60 Cr | 0.66 Cr | 0.48 Cr | — |
| Accounts Payable | 0.54 Cr | 0.60 Cr | 0.65 Cr | 0.48 Cr | — |
| Total Assets | 11.82 Cr | 11.36 Cr | 10.23 Cr | 9.93 Cr | — |
| Total Non Current Assets | 2.80 Cr | 2.62 Cr | 2.40 Cr | 2.55 Cr | — |
| Other Non Current Assets | 0.06 Cr | -1000.00 | 0.02 Cr | 0.02 Cr | — |
| Investmentin Financial Assets | 1.04 Cr | 1.02 Cr | 0.66 Cr | 0.67 Cr | — |
| Net PPE | 1.70 Cr | 1.58 Cr | 1.71 Cr | 1.86 Cr | — |
| Current Assets | 9.02 Cr | 8.74 Cr | 7.84 Cr | 7.38 Cr | — |
| Other Current Assets | 2.02 Cr | 1000.00 | 0.03 Cr | -1000.00 | — |
| Inventory | 0.78 Cr | 0.85 Cr | 0.94 Cr | 0.93 Cr | — |
| Accounts Receivable | 0.66 Cr | 0.86 Cr | 1.13 Cr | 1.21 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 5.55 Cr | 7.00 Cr | 5.73 Cr | 5.21 Cr | — |
| Other Short Term Investments | 3.15 Cr | 4.05 Cr | 3.76 Cr | 3.12 Cr | — |
| Cash And Cash Equivalents | 2.40 Cr | 2.95 Cr | 1.97 Cr | 2.09 Cr | — |
| Retained Earnings | — | 2.96 Cr | 2.47 Cr | 2.01 Cr | 1.67 Cr |
| Additional Paid In Capital | — | 2.55 Cr | 2.55 Cr | 1.52 Cr | 1.52 Cr |
| Other Non Current Liabilities | — | 1000.00 | 1000.00 | 0.04 Cr | 1000.00 |
| Current Deferred Taxes Liabilities | — | 0.03 Cr | 0.04 Cr | 0.06 Cr | 0.23 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 0.09 Cr | 0.09 Cr | 0.13 Cr | 0.13 Cr |
| Total Tax Payable | — | 0.00 | 24000.00 | 17000.00 | 0.01 Cr |
| Non Current Prepaid Assets | — | 0.02 Cr | 0.02 Cr | 0.02 Cr | 0.07 Cr |
| Available For Sale Securities | — | 1.02 Cr | 0.66 Cr | 0.67 Cr | 0.61 Cr |
| Goodwill And Other Intangible Assets | — | 0.00 | 0.00 | 0.00 | — |
| Accumulated Depreciation | — | -4.60 Cr | -4.46 Cr | -5.05 Cr | -4.85 Cr |
| Gross PPE | — | 6.17 Cr | 6.17 Cr | 6.91 Cr | 6.88 Cr |
| Construction In Progress | — | 0.00 | 0.00 | 0.00 | — |
| Other Properties | — | 0.61 Cr | 0.61 Cr | 0.77 Cr | 0.73 Cr |
| Machinery Furniture Equipment | — | 2.24 Cr | 2.24 Cr | 2.83 Cr | 2.83 Cr |
| Buildings And Improvements | — | 3.06 Cr | 3.06 Cr | 3.06 Cr | 3.06 Cr |
| Land And Improvements | — | 0.26 Cr | 0.26 Cr | 0.26 Cr | 0.26 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 0.01 Cr | 0.01 Cr | 0.02 Cr | 0.05 Cr |
| Other Inventories | — | 0.02 Cr | 0.01 Cr | 0.03 Cr | 0.03 Cr |
| Finished Goods | — | 0.75 Cr | 0.83 Cr | 0.80 Cr | 1.13 Cr |
| Work In Process | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Raw Materials | — | 0.08 Cr | 0.09 Cr | 0.09 Cr | 0.09 Cr |
| Other Receivables | — | 0.02 Cr | 0.02 Cr | 0.02 Cr | — |
| Cash Financial | — | 2.95 Cr | 1.97 Cr | 2.09 Cr | 1.39 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Colinz Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.